This company listing is no longer active
La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Nemaura Medical Croissance future
Future contrôle des critères 2/6
Nemaura Medical's earnings are forecast to decline at 20.8% per annum while its annual revenue is expected to grow at 214.5% per year. EPS is expected to decline by 19.1% per annum.
Informations clés
-20.8%
Taux de croissance des bénéfices
-19.1%
Taux de croissance du BPA
| Medical Equipment croissance des bénéfices | 16.2% |
| Taux de croissance des recettes | 214.5% |
| Rendement futur des capitaux propres | n/a |
| Couverture par les analystes | Low |
| Dernière mise à jour | 22 Feb 2024 |
Mises à jour récentes de la croissance future
Pas de mise à jour
Recent updates
Prévisions de croissance des bénéfices et des revenus
| Date | Recettes | Les revenus | Flux de trésorerie disponible | Cash from Op | Moy. Nombre d'analystes |
|---|---|---|---|---|---|
| 3/31/2025 | 1 | -13 | N/A | -11 | 1 |
| 3/31/2024 | 0 | -9 | N/A | -7 | 1 |
| 12/31/2023 | N/A | -11 | -10 | -10 | N/A |
| 9/30/2023 | 0 | -10 | -10 | -10 | N/A |
| 6/30/2023 | 0 | -13 | -9 | -9 | N/A |
| 3/31/2023 | 0 | -14 | -9 | -8 | N/A |
| 12/31/2022 | 0 | -13 | -9 | -8 | N/A |
| 9/30/2022 | 1 | -15 | -8 | -8 | N/A |
| 6/30/2022 | 1 | -14 | -8 | -7 | N/A |
| 3/31/2022 | 1 | -14 | -7 | -7 | N/A |
| 12/31/2021 | 0 | -12 | -7 | -6 | N/A |
| 9/30/2021 | N/A | -10 | -8 | -6 | N/A |
| 6/30/2021 | N/A | -9 | -8 | -7 | N/A |
| 3/31/2021 | N/A | -6 | -7 | -6 | N/A |
| 12/31/2020 | N/A | -5 | -6 | -6 | N/A |
| 9/30/2020 | N/A | -4 | -5 | -5 | N/A |
| 6/30/2020 | N/A | -4 | -4 | -4 | N/A |
| 3/31/2020 | N/A | -4 | -4 | -3 | N/A |
| 12/31/2019 | N/A | -4 | -4 | -4 | N/A |
| 9/30/2019 | N/A | -5 | -4 | -4 | N/A |
| 6/30/2019 | N/A | -5 | -4 | -4 | N/A |
| 3/31/2019 | N/A | -4 | -4 | -4 | N/A |
| 12/31/2018 | N/A | -3 | -3 | -3 | N/A |
| 9/30/2018 | N/A | -3 | -3 | -3 | N/A |
| 6/30/2018 | N/A | -2 | -2 | -2 | N/A |
| 3/31/2018 | N/A | -2 | -2 | -2 | N/A |
| 12/31/2017 | N/A | -2 | -2 | -2 | N/A |
| 9/30/2017 | N/A | -2 | N/A | -2 | N/A |
| 6/30/2017 | N/A | -1 | N/A | -1 | N/A |
| 3/31/2017 | N/A | -2 | N/A | -1 | N/A |
| 12/31/2016 | N/A | -2 | N/A | -1 | N/A |
| 9/30/2016 | N/A | -2 | N/A | -1 | N/A |
| 6/30/2016 | N/A | -2 | N/A | -1 | N/A |
| 3/31/2016 | N/A | -2 | N/A | -1 | N/A |
| 12/31/2015 | N/A | -2 | N/A | -1 | N/A |
| 9/30/2015 | N/A | -1 | N/A | -1 | N/A |
| 6/30/2015 | N/A | -1 | N/A | -1 | N/A |
| 3/31/2015 | N/A | -1 | N/A | -1 | N/A |
| 12/31/2014 | N/A | -1 | N/A | 0 | N/A |
| 9/30/2014 | N/A | -1 | N/A | 1 | N/A |
| 6/30/2014 | N/A | -1 | N/A | 1 | N/A |
| 3/31/2014 | N/A | -1 | N/A | 2 | N/A |
Prévisions de croissance des analystes
Taux de revenus par rapport au taux d'épargne: N18A is forecast to remain unprofitable over the next 3 years.
Bénéfices vs marché: N18A is forecast to remain unprofitable over the next 3 years.
Croissance élevée des bénéfices: N18A is forecast to remain unprofitable over the next 3 years.
Chiffre d'affaires vs marché: N18A's revenue (214.5% per year) is forecast to grow faster than the German market (5.5% per year).
Croissance élevée des revenus: N18A's revenue (214.5% per year) is forecast to grow faster than 20% per year.
Prévisions de croissance du bénéfice par action
Rendement futur des capitaux propres
ROE futur: Insufficient data to determine if N18A's Return on Equity is forecast to be high in 3 years time